CataX AI raises RMB 40 million seed round
AI summary
According to 36Kr, Shanghai-based CataX AI announced a RMB 40 million seed financing round incubated and solely invested in by Qiming Venture Partners. The company is described as an agent-native innovative drug developer focused on clinical development through its “Clinical-of-One” model. It plans to pursue licensing or co-development for preclinical and early clinical assets with the goal of achieving proof of concept.
登录
搜索